Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy

Eric Lazear, Reza Ghasemi, Sarah M. Hein, John Westwick, Dan Watkins, Daved H. Fremont, Alexander Sasha Krupnick

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The use of high-dose interleukin-2 (IL-2) has fallen out of favor due to severe life-threatening side effects. We have recently described a unique way of directly targeting IL-2 to cytotoxic lymphocytes using a virally encoded immune evasion protein and an IL-2 mutant that avoids off-target side effects such as activation of regulatory T cells and vascular endothelium.

Original languageEnglish
Article numbere1265721
JournalOncoImmunology
Volume6
Issue number2
DOIs
StatePublished - Feb 1 2017

Keywords

  • Cytokine
  • Interleukin-2 (IL-2)
  • NKG2D
  • cytotoxic lymphocytes
  • immunotargeting
  • immunotherapy
  • natural killer cell (NK)

Fingerprint Dive into the research topics of 'Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy'. Together they form a unique fingerprint.

  • Cite this